Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 11 - 20 of 34 items for :

  • "treatment initiation" x
Clear All
Juliane Léger Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France

Search for other papers by Juliane Léger in
Google Scholar
PubMed Close
,
Anne Fjellestad-Paulsen Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Anne Fjellestad-Paulsen in
Google Scholar
PubMed Close
,
Anne Bargiacchi Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Anne Bargiacchi in
Google Scholar
PubMed Close
,
Catherine Doyen Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Catherine Doyen in
Google Scholar
PubMed Close
,
Emmanuel Ecosse Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Emmanuel Ecosse in
Google Scholar
PubMed Close
,
Jean-Claude Carel Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service d’Endocrinologie Diabétologie Pédiatrique, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France
Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 1141, DHU PROTECT, Paris, France

Search for other papers by Jean-Claude Carel in
Google Scholar
PubMed Close
, and
Marie-France Le Heuzey Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Service de Psychiatrie de l’Enfant et de l’Adolescent, Centre de Référence des Maladies Endocriniennes de la Croissance et du développement, Paris, France

Search for other papers by Marie-France Le Heuzey in
Google Scholar
PubMed Close

study, from −2.9 ± 1.1 SDS at its lowest to −1.3 ± 1.3 SDS one year before study entry and −0.9 ± 0.6 SDS at the time of GH treatment initiation ( Fig. 1 ), HV remained low in all patients, at a median (25–75th percentiles) of 1.0 (0.7−2.1) cm/year at

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0200
Volume/Issue:
Volume 6: Issue 8
Open access
Lukas Plachy Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Lukas Plachy in
Google Scholar
PubMed Close
,
Petra Dusatkova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Petra Dusatkova in
Google Scholar
PubMed Close
,
Klara Maratova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Klara Maratova in
Google Scholar
PubMed Close
,
Shenali Anne Amaratunga Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed Close
,
Dana Zemkova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Dana Zemkova in
Google Scholar
PubMed Close
,
Vit Neuman Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Vit Neuman in
Google Scholar
PubMed Close
,
Stanislava Kolouskova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed Close
,
Barbora Obermannova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Barbora Obermannova in
Google Scholar
PubMed Close
,
Marta Snajderova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Marta Snajderova in
Google Scholar
PubMed Close
,
Zdenek Sumnik Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed Close
,
Jan Lebl Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Jan Lebl in
Google Scholar
PubMed Close
, and
Stepanka Pruhova Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu, Prague, Czech Republic

Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed Close

consented to genetic testing and were enrolled in the study. Their age at study enrollment, first endocrinological examination, and GH treatment initiation was 11.2 years (median; IQR: 8.2–14.4 years), 2.5 years (1.3–4.9 years), and 2.7 years (1.6–5.7 years

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-24-0217
Volume/Issue:
Volume 13: Issue 10
Open access
Charlotte Höybye Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Andreas F H Pfeiffer Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Klinik für Endokrinologie & Stoffwechselmedizin, Berlin, Germany

Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed Close
,
Diego Ferone IRCCS AOU San Martino-IST, Università di Genova – Endocrinologia DiMI, Dipartimento di Medicina Interna e Specialità Mediche, & CEBR, Centro di Eccellenza per la Ricerca Biomedica, Genova, Italy

Search for other papers by Diego Ferone in
Google Scholar
PubMed Close
,
Jens Sandahl Christiansen Medicinsk Endokrinologist Afd., MEA, NBG, Århus Sygehus, Århus, Denmark

Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed Close
,
David Gilfoyle Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by David Gilfoyle in
Google Scholar
PubMed Close
,
Eva Dam Christoffersen Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Eva Dam Christoffersen in
Google Scholar
PubMed Close
,
Eva Mortensen Ascendis Pharma Inc., Palo Alto, California, USA

Search for other papers by Eva Mortensen in
Google Scholar
PubMed Close
,
Jonathan A Leff Ascendis Pharma Inc., Palo Alto, California, USA

Search for other papers by Jonathan A Leff in
Google Scholar
PubMed Close
, and
Michael Beckert Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Michael Beckert in
Google Scholar
PubMed Close

TransCon GH 0.02 mg/kg/week. Six days after treatment initiation, she again experienced a severe adrenal crisis requiring hospitalization. After recovery, she experienced a second SAE, moderate pleuritic chest pain likely caused by a pulmonary infiltrate

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0007
Volume/Issue:
Volume 6: Issue 3
Open access
Nikolina Zdraveska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Nikolina Zdraveska in
Google Scholar
PubMed Close
,
Maja Zdravkovska Institute of Patophysiology and Nuclear Medicine, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Maja Zdravkovska in
Google Scholar
PubMed Close
,
Violeta Anastasovska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Violeta Anastasovska in
Google Scholar
PubMed Close
,
Elena Sukarova-Angelovska University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Elena Sukarova-Angelovska in
Google Scholar
PubMed Close
, and
Mirjana Kocova University Children’s Hospital Skopje, Faculty of Medicine, Skopje, Republic of Macedonia

Search for other papers by Mirjana Kocova in
Google Scholar
PubMed Close

Statistical analysis was performed using the SPSS for Windows statistical package (version 17.0). The following variables were analyzed: gestational age, sex, birthweight, initial values of TSH and T 4 , age at treatment initiation, initial LT 4 dose, LT 4

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0332
Volume/Issue:
Volume 7: Issue 2
Open access
Raja Padidela Royal Manchester Children’s Hospital and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Search for other papers by Raja Padidela in
Google Scholar
PubMed Close
,
Moira S Cheung Evelina London Children’s Hospital, London, UK

Search for other papers by Moira S Cheung in
Google Scholar
PubMed Close
,
Vrinda Saraff Birmingham Women’s and Children’s Hospital, Birmingham, UK

Search for other papers by Vrinda Saraff in
Google Scholar
PubMed Close
, and
Poonam Dharmaraj Alder Hey Children’s NHS Foundation Trust, Liverpool, UK

Search for other papers by Poonam Dharmaraj in
Google Scholar
PubMed Close

should stop oral phosphate and active vitamin D analogues 7 days prior to commencing burosumab treatment ( https://www.ema.europa.eu/en/documents/product-information/crysvita-epar-product-information_en.pdf ). Immediately prior to treatment initiation

Article Type:
Research Article
Collections:
Paediatric Endocrinology Collection
DOI:
https://doi.org/10.1530/EC-20-0291
Volume/Issue:
Volume 9: Issue 10
Open access
Maria Stelmachowska-Banaś Department of Endocrinology, The Centre of Postgraduate Medical Education, Warsaw, Polska, Poland

Search for other papers by Maria Stelmachowska-Banaś in
Google Scholar
PubMed Close
and
Izabella Czajka-Oraniec Department of Endocrinology, The Centre of Postgraduate Medical Education, Warsaw, Polska, Poland

Search for other papers by Izabella Czajka-Oraniec in
Google Scholar
PubMed Close

ipilimumab-induced IH after the third drug infusion ( 16 , 35 ), while anti-PD-1/PD-L1-induced IH might be expected months after treatment initiation ( 25 , 36 ). Clinical characteristics Symptoms of IH can be relatively non-specific and progress

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0342
Volume/Issue:
Volume 9: Issue 10
Open access
Vânia Benido Silva Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed Close
,
Liliana Fonseca Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Liliana Fonseca in
Google Scholar
PubMed Close
,
Maria Teresa Pereira Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Maria Teresa Pereira in
Google Scholar
PubMed Close
,
Joana Vilaverde Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Joana Vilaverde in
Google Scholar
PubMed Close
,
Clara Pinto Department of Obstetrics, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Clara Pinto in
Google Scholar
PubMed Close
,
Fernando Pichel Department of Nutrition, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Fernando Pichel in
Google Scholar
PubMed Close
,
Maria do Céu Almeida In representation of the Diabetes and Pregnancy Study Group of the Portuguese Society of Diabetology, Lisbon, Portugal

Search for other papers by Maria do Céu Almeida in
Google Scholar
PubMed Close
, and
Jorge Dores Department of Endocrinology, Centro Hospitalar Universitário do Porto, Porto, Portugal

Search for other papers by Jorge Dores in
Google Scholar
PubMed Close

control. Higher pregestational BMI and fasting PG levels in OGTT, earlier GDM diagnosis and metformin treatment initiation, and hypertension increased the risk of metformin monotherapy failure, although only the BMI value, fasting PG levels in OGTT and

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-21-0540
Volume/Issue:
Volume 11: Issue 5
Open access
Gudmundur Johannsson Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed Close
,
Martin Bidlingmaier Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed Close
,
Margaret Boguszewski Federal University of Parana, Curitiba, Brazil

Search for other papers by Margaret Boguszewski in
Google Scholar
PubMed Close
,
Felipe F Casanueva Department of Medicine, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain

Search for other papers by Felipe F Casanueva in
Google Scholar
PubMed Close
,
Philippe Chanson Assistance Publique-Hôpitaux de Paris, and Inserm, Paris, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed Close
,
Peter E Clayton Developmental Biology & Medicine, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK

Search for other papers by Peter E Clayton in
Google Scholar
PubMed Close
,
Catherine S Choong Department of Endocrinology, Princess Margaret Hospital & School of Medicine, University of Western Australia, Western Australia, Australia

Search for other papers by Catherine S Choong in
Google Scholar
PubMed Close
,
David Clemmons Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA

Search for other papers by David Clemmons in
Google Scholar
PubMed Close
,
Mehul Dattani Great Ormond Street Institute of Child Health, London, UK

Search for other papers by Mehul Dattani in
Google Scholar
PubMed Close
,
Jan Frystyk Department of Endocrinology, Odense University Hospital, Odense, Denmark

Search for other papers by Jan Frystyk in
Google Scholar
PubMed Close
,
Ken Ho Princess Alexandra Hospital and University of Queensland, Brisbane, Australia

Search for other papers by Ken Ho in
Google Scholar
PubMed Close
,
Andrew R Hoffman Department of Medicine, Stanford University and VA Palo Health Care System, Palo Alto, California, USA

Search for other papers by Andrew R Hoffman in
Google Scholar
PubMed Close
,
Reiko Horikawa National Center for Child Health and Development, Tokyo, Japan

Search for other papers by Reiko Horikawa in
Google Scholar
PubMed Close
,
Anders Juul Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close
,
John J Kopchick Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

Search for other papers by John J Kopchick in
Google Scholar
PubMed Close
,
Xiaoping Luo Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Search for other papers by Xiaoping Luo in
Google Scholar
PubMed Close
,
Sebastian Neggers Section of Endocrinology, Department of Medicine, Pituitary Centre Rotterdam, Erasmus University Medical Centre, Rotterdam, the Netherlands

Search for other papers by Sebastian Neggers in
Google Scholar
PubMed Close
,
Irene Netchine Service d’Explorations Fonctionnelles Endocriniennes, AP-HP, Hôpital Trousseau, Sorbonne Université, INSERM UMRs 938, Paris, France

Search for other papers by Irene Netchine in
Google Scholar
PubMed Close
,
Daniel S Olsson Department of Endocrinology, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Daniel S Olsson in
Google Scholar
PubMed Close
,
Sally Radovick Rutgers University-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

Search for other papers by Sally Radovick in
Google Scholar
PubMed Close
,
Ron Rosenfeld Department of Pediatrics, Oregon Health Science University, Portland, Oregon, USA

Search for other papers by Ron Rosenfeld in
Google Scholar
PubMed Close
,
Richard J Ross University of Sheffield, Sheffield, UK

Search for other papers by Richard J Ross in
Google Scholar
PubMed Close
,
Katharina Schilbach Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Katharina Schilbach in
Google Scholar
PubMed Close
,
Paulo Solberg Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

Search for other papers by Paulo Solberg in
Google Scholar
PubMed Close
,
Christian Strasburger Charité-Universitätsmedizin, Berlin, Germany

Search for other papers by Christian Strasburger in
Google Scholar
PubMed Close
,
Peter Trainer The Christie NHS Foundation Trust, University of Manchester, Manchester, UK

Search for other papers by Peter Trainer in
Google Scholar
PubMed Close
,
Kevin C J Yuen Barrow Pituitary Center, Barrow Neurological Institute, Department of Neuroendocrinology, University of Arizona College of Medicine, Phoenix, Arizona, USA

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed Close
,
Kerstin Wickstrom Medical Products Agency, Uppsala, Sweden

Search for other papers by Kerstin Wickstrom in
Google Scholar
PubMed Close
,
Jens O L Jorgensen Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Jens O L Jorgensen in
Google Scholar
PubMed Close
, and
on behalf of the Growth Hormone Research Society
Search for other papers by on behalf of the Growth Hormone Research Society in
Google Scholar
PubMed Close

in paediatric patients ( 45 ). Conclusion Adult height remains the clinical endpoint of GH treatment in paediatric patients, and height velocity during the first and second year after treatment initiation is useful surrogate endpoints. In

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0047
Volume/Issue:
Volume 7: Issue 3
Open access
Shota Dzemaili University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland

Search for other papers by Shota Dzemaili in
Google Scholar
PubMed Close
,
Jitske Tiemensma University of California Merced, Psychological Science, Merced, CA, USA

Search for other papers by Jitske Tiemensma in
Google Scholar
PubMed Close
,
Richard Quinton Department of Endocrinology, Institute for Human Genetics, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, United Kingdom

Search for other papers by Richard Quinton in
Google Scholar
PubMed Close
,
Nelly Pitteloud Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed Close
,
Diane Morin University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland
Faculty of Nursing Science, Laval University, Québec City, Canada

Search for other papers by Diane Morin in
Google Scholar
PubMed Close
, and
Andrew A Dwyer University of Lausanne, Institute of Higher Education and Research in Healthcare, Lausanne, Switzerland
Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Search for other papers by Andrew A Dwyer in
Google Scholar
PubMed Close

compounded by late diagnosis, as up to 90% of adult bone mass is accumulated during adolescence ( 40 ). Delays in diagnosis (and treatment initiation) could prolong estrogen deficiency thus impairing bone mineralization. These data highlight the importance of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0095
Volume/Issue:
Volume 6: Issue 6
Open access
Benjamin G Challis Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
IMED Biotech Unit, Clinical Discovery Unit, AstraZeneca, UK

Search for other papers by Benjamin G Challis in
Google Scholar
PubMed Close
,
Andrew S Powlson Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Andrew S Powlson in
Google Scholar
PubMed Close
,
Ruth T Casey Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed Close
,
Carla Pearson Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Carla Pearson in
Google Scholar
PubMed Close
,
Brian Y Lam Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Brian Y Lam in
Google Scholar
PubMed Close
,
Marcella Ma Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Marcella Ma in
Google Scholar
PubMed Close
,
Deborah Pitfield Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Deborah Pitfield in
Google Scholar
PubMed Close
,
Giles S H Yeo Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Giles S H Yeo in
Google Scholar
PubMed Close
,
Edmund Godfrey Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Edmund Godfrey in
Google Scholar
PubMed Close
,
Heok K Cheow Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Heok K Cheow in
Google Scholar
PubMed Close
,
V Krishna Chatterjee Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke’s Hospital, Cambridge, UK
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by V Krishna Chatterjee in
Google Scholar
PubMed Close
,
Nicholas R Carroll Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Nicholas R Carroll in
Google Scholar
PubMed Close
,
Ashley Shaw Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Ashley Shaw in
Google Scholar
PubMed Close
,
John R Buscombe Department of Radiology, Addenbrooke’s Hospital, Cambridge, UK
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by John R Buscombe in
Google Scholar
PubMed Close
, and
Helen L Simpson Department of Diabetes and Endocrinology, UCLH NHS Foundation Trust, London, UK

Search for other papers by Helen L Simpson in
Google Scholar
PubMed Close

-insulin-secreting pNET died during the treatment course, whilst a second patient with metastatic insulinoma commenced concomitant systemic chemotherapy (streptozocin and capecitabine). This patient died shortly after treatment initiation. Two patients with malignant

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0076
Volume/Issue:
Volume 6: Issue 7
Open access